Venus Remedies Ltd.

BSE: VENUSREM526953ISIN INE411B01019

Healthcare
Pharmaceuticals
BSE Healthcare

Share price

₹1,384.95+65.95 (+5.00%)

as of 4 Nov 2026

Prices adjusted for splits and bonuses; cash dividends excluded. Volume shows actual shares traded.

52W high: ₹2,043.15
52W low: ₹438.00
Off 52W high: -32.21%
1M return: -20.94%
3M return: -9.10%
6M return: +49.81%
1Y return: +212.42%
20D avg volume: 4,998
50 DMA: ₹1,583.59
200 DMA: ₹1,293.84

Key ratios Consolidated

Market cap: ₹1,851 Cr
Current price: ₹1,384.95
52W high / low: ₹2,043.15 / ₹438.00
Face value: ₹10.00
P/E: 15.21
P/B: 2.63
EPS (TTM): ₹91.04
Book value / share: ₹526.93
ROE: —
ROCE: 19.40%
Operating margin: —
Net margin: —
Debt / equity: 0.00
Net debt: ₹-25.12 Cr
Interest cover: 3,354.75
Dividend yield: 0.72%
Dividend / share (TTM): ₹10.00
Payout: 10.98%
Cash conversion cycle: 56.6 days

Financials

Metric	Q2 FY27	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24
Income statement
	218.76	178.86	259.40	180.26	192.75	131.90	194.97	176.86	167.45	108.61	195.16	143.42
	0.51	2.62	4.95	2.52	1.71	8.69	6.76	2.03	10.58	1.59	3.92	2.35
	219.27	181.48	264.35	182.78	194.46	140.59	201.73	178.89	178.03	110.20	199.08	145.77
	185.80	151.44	202.75	149.31	167.97	127.98	170.69	163.92	168.96	103.35	181.62	137.99
	97.39	83.14	116.28	93.86	106.51	71.33	104.21	97.52	77.45	69.58	84.17	87.31
	2.14	1.12	4.73	1.90	1.86	2.27	2.13	5.50	8.38	9.03	2.67	2.63
	26.53	23.37	24.56	20.83	22.97	20.30	21.16	19.55	21.57	18.21	19.71	17.35
	0.00	0.00	0.01	0.01	0.01	0.01	0.01	0.01	0.02	0.02	0.02	0.07
	9.54	6.77	6.76	6.56	6.17	6.18	4.71	5.41	6.40	5.98	5.91	6.54
	43.47	37.02	51.86	35.66	31.51	27.34	41.75	—	—	—	—	—
	33.47	30.04	61.60	33.47	26.49	12.61	31.04	14.97	9.07	6.85	17.46	7.78
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	9.91	0.00	0.00	0.00	0.00
	33.47	30.04	61.60	33.47	26.49	12.61	31.04	24.88	9.07	6.85	17.46	7.78
	7.82	7.07	14.11	7.89	6.36	3.01	7.11	5.28	5.56	5.63	6.96	0.93
	25.65	22.97	47.49	25.58	20.13	9.60	21.00	19.60	3.52	1.22	10.51	6.85
	19.19	17.18	35.53	19.14	15.06	7.18	15.71	14.66	2.63	0.92	7.86	5.13
Key metrics
	43.01	36.81	68.37	40.04	32.67	18.80	35.76	30.30	15.49	12.85	23.39	14.39
	19.70%	20.60%	26.40%	22.20%	16.90%	14.30%	18.30%	17.10%	9.30%	11.80%	12.00%	10.00%
	11.70%	12.80%	18.30%	14.20%	10.40%	7.30%	10.80%	11.10%	2.10%	1.10%	5.40%	4.80%
	4.60%	—	8.90%	—	4.20%	—	5.40%	—	—	—	—	—
	13.50%	35.60%	33.00%	1.90%	15.10%	21.40%	-0.10%	23.30%	—	—	—	—
	27.40%	139.30%	126.10%	30.50%	471.90%	686.90%	99.80%	186.10%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22
Income statement
	837.28	769.60	647.89	601.45	555.51	598.65
	10.60	12.58	20.96	11.58	10.32	8.31
	847.88	782.18	668.85	613.03	565.83	606.96
	689.30	648.03	606.93	568.38	527.90	570.55
	390.67	387.98	348.77	344.28	317.79	381.97
	9.89	10.76	25.04	13.07	5.16	—
	95.29	88.68	80.49	71.50	61.33	52.33
	0.02	0.04	0.07	0.09	0.29	0.48
	29.63	25.67	22.51	26.44	32.30	33.53
	168.01	146.37	125.24	—	—	—
	158.58	134.15	61.92	44.65	37.93	36.41
	0.00	0.00	9.91	0.00	0.00	0.00
	158.58	134.15	71.83	44.65	37.93	36.41
	36.89	31.37	23.58	16.15	11.36	4.32
	121.69	102.78	45.32	28.50	26.57	40.72
	91.04	76.89	33.90	21.31	19.88	30.86
Key metrics
	188.23	159.86	94.41	71.18	70.52	70.42
	22.48%	20.80%	14.60%	11.80%	12.70%	11.80%
	14.53%	13.40%	7.00%	4.70%	4.80%	6.80%
	—	19.40%	12.40%	—	—	—
	20.22%	18.80%	7.70%	8.30%	-7.20%	—
	73.03%	126.80%	59.00%	7.30%	-34.70%	—
	—	118.11	76.82	—	—	—
	—	1.52	1.91	—	—	—
	—	0.00	0.00	—	—	—
	—	-25.12	-55.83	—	—	—
	—	56.6	68.0	—	—	—
Balance sheet
	—	853.71	715.72	—	—	—
	—	395.21	451.72	—	—	—
	—	25.12	57.52	—	—	—
	—	103.28	112.22	—	—	—
	—	129.37	100.49	—	—	—
	—	50.44	63.10	—	—	—
	—	125.43	124.70	—	—	—
	—	113.49	91.86	—	—	—
	—	161.76	136.29	—	—	—
	—	0.00	1.69	—	—	—
	—	0.00	1.69	—	—	—
	—	0.00	0.00	—	—	—
	—	663.75	560.95	—	—	—
Cash flow
	—	155.76	86.45	—	—	—
	—	-181.56	-76.25	—	—	—
	—	-3.12	-1.02	—	—	—
	—	37.65	9.63	—	—	—

Metric	Q2 FY27	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24
Income statement
	218.76	178.80	259.01	179.95	192.65	131.85	194.04	172.54	167.02	105.86	175.16	131.23
	0.40	2.55	4.64	2.41	1.68	8.00	6.77	1.74	10.71	1.56	3.91	2.42
	219.16	181.35	263.65	182.36	194.33	139.85	200.81	174.28	177.73	107.42	179.07	133.65
	182.39	148.75	206.07	149.55	168.73	125.15	175.98	154.83	162.92	97.34	159.59	124.53
	97.39	83.14	116.25	93.86	106.51	71.33	104.21	97.61	77.41	69.59	89.54	87.21
	2.13	1.12	4.73	1.90	1.87	2.27	2.13	5.50	8.38	9.03	2.67	2.63
	25.82	22.56	23.62	19.94	22.03	19.26	19.32	17.39	19.45	16.08	17.21	15.12
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—	—
	9.27	6.51	6.50	6.32	5.92	5.95	4.49	5.20	6.17	5.76	5.72	6.30
	41.05	35.40	56.42	37.04	33.46	25.79	49.83	—	—	—	—	—
	36.77	32.60	57.58	32.81	25.60	14.70	24.83	19.45	14.81	10.08	19.48	9.12
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	9.91	—	—	—	—
	36.77	32.60	57.58	32.81	25.60	14.70	24.83	29.36	14.81	10.08	19.48	9.12
	7.81	7.07	14.11	7.89	6.36	3.01	7.11	5.28	5.55	5.63	6.96	0.93
	28.96	25.53	43.47	24.92	19.24	11.69	14.79	24.08	9.26	4.45	12.52	8.19
	21.66	19.10	32.51	18.64	14.40	8.75	11.07	18.02	6.92	3.33	9.36	6.13
Key metrics
	46.04	39.11	64.08	39.13	31.52	20.65	29.32	34.56	20.98	15.84	25.20	15.42
	21.00%	21.90%	24.70%	21.70%	16.40%	15.70%	15.10%	20.00%	12.60%	15.00%	14.40%	11.80%
	13.20%	14.30%	16.80%	13.80%	10.00%	8.90%	7.60%	14.00%	5.50%	4.20%	7.10%	6.20%
	4.80%	—	8.00%	—	3.90%	—	4.10%	—	—	—	—	—
	13.60%	35.60%	33.50%	4.30%	15.30%	24.60%	10.80%	31.50%	—	—	—	—
	50.50%	118.40%	193.90%	3.50%	107.80%	162.70%	18.10%	194.00%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22
Income statement
	836.52	768.73	639.46	575.21	537.66	575.18
	10.00	11.45	20.78	11.32	10.17	8.43
	846.52	780.18	660.24	586.53	547.83	583.61
	686.76	649.50	591.09	539.88	507.50	538.94
	390.64	387.95	348.82	344.15	317.28	372.78
	9.88	10.76	25.04	13.07	5.16	—
	91.94	84.85	72.24	62.13	51.95	43.75
	0.00	0.00	0.00	—	—	—
	28.60	24.69	21.62	25.55	31.37	32.58
	169.91	152.72	122.44	—	—	—
	159.76	130.68	69.15	46.65	40.33	44.67
	0.00	0.00	9.91	—	—	—
	159.76	130.68	79.06	46.65	40.33	44.67
	36.88	31.37	23.58	16.15	11.37	4.32
	122.88	99.31	52.55	30.50	28.96	48.99
	91.91	74.29	39.32	22.82	24.67	37.12
Key metrics
	188.36	155.37	100.68	72.20	71.70	77.25
	22.52%	20.20%	15.70%	12.60%	13.30%	13.40%
	14.69%	12.90%	8.20%	5.30%	5.40%	8.50%
	—	18.20%	13.00%	—	—	—
	21.05%	20.20%	11.20%	7.00%	-6.50%	—
	76.05%	89.00%	72.30%	5.30%	-40.90%	—
	—	113.43	73.52	—	—	—
	—	1.52	1.58	—	—	—
	—	0.00	0.00	—	—	—
	—	-23.54	-55.41	—	—	—
	—	64.1	74.9	—	—	—
Balance sheet
	—	876.06	713.22	—	—	—
	—	405.81	435.75	—	—	—
	—	23.54	55.41	—	—	—
	—	116.39	99.26	—	—	—
	—	129.37	100.49	—	—	—
	—	49.68	62.68	—	—	—
	—	110.23	110.93	—	—	—
	—	110.77	68.61	—	—	—
	—	158.23	105.24	—	—	—
	—	0.00	0.00	—	—	—
	—	0.00	0.00	—	—	—
	—	0.00	0.00	—	—	—
	—	689.63	589.50	—	—	—
Cash flow
	—	151.09	83.10	—	—	—
	—	-181.57	-76.20	—	—	—
	—	-1.39	0.00	—	—	—
	—	37.66	9.58	—	—	—

Compounded growth

Standalone

Sales CAGR 3Y: +12.66%
Sales CAGR 5Y: —
Profit CAGR 3Y: +50.80%
Profit CAGR 5Y: —
Sales YoY (TTM): +21.05%
Profit YoY (TTM): +76.05%

Consolidated

Sales CAGR 3Y: +11.48%
Sales CAGR 5Y: —
Profit CAGR 3Y: +56.98%
Profit CAGR 5Y: —
Sales YoY (TTM): +20.22%
Profit YoY (TTM): +73.03%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Sep 2026

Promoter holding: 41.76%

Quarter	September 2026	June 2026
Promoter %	41.76%	41.76%

Holder	Type	Holding	Previous	Change
Sunev Pharma Solutions Pvt Ltd	Promoter Group	17.21%	17.21%	0.00%
PAWAN CHAUDHARY	Promoter	12.82%	12.82%	0.00%
MANU CHAUDHARY	Promoter	11.73%	11.73%	0.00%
TIKRI PARTNERS LLP	Public	1.97%	1.97%	0.00%
RAJNI TARUN JAIN	Public	1.42%	1.42%	0.00%
ACADIAN EMERGING MARKETS MICRO-CAP EQUITY MASTER FUND	Public	1.10%	1.10%	0.00%
NISARG AJAYKUMAR VAKHARIA	Public	1.05%	1.05%	0.00%
INVESTOR EDUCATION AND PROTECTION FUND AUTHORITY MINISTRY OF CORPORATE AFFAIRS	Public	1.00%	—	—
Radha Luxmi Investments	Promoter Group	0.00%	0.00%	0.00%
ADITI K CHAUDHARY	Promoter Group	0.00%	0.00%	0.00%
ALKA JAIN	Promoter Group	0.00%	0.00%	0.00%
Plea Charitable Trust	Promoter Group	0.00%	0.00%	0.00%
Spine Software Systems Pvt Lt	Promoter Group	0.00%	0.00%	0.00%
Tark AI Pvt Ltd	Promoter Group	0.00%	0.00%	0.00%
PEEYUSH JAIN	Promoter Group	0.00%	0.00%	0.00%

Public shareholders are disclosed individually only above 1%.

Peer comparison

Company	Mkt cap (₹ Cr)	Price (₹)	P/E	ROCE	Sales YoY	Profit YoY	1Y return
Sun Pharmaceutical Industries Ltd.	4,26,112	1,776.00	38.78	17.90%	+12.13% TTM	+4.79% TTM	+4.92%
Divi's Laboratories Ltd.	2,66,424	10,036.00	91.09	19.00%	+16.35% TTM	+26.84% TTM	+47.61%
Torrent Pharmaceuticals Ltd.	1,79,908	4,730.00	85.71	9.10%	+42.06% TTM	-1.92% TTM	+32.24%
Laurus Labs Limited	1,24,601	2,306.10	93.53	19.70%	+23.03% TTM	+95.38% TTM	+134.59%
Zydus Lifesciences Limited	1,18,703	1,190.00	25.85	19.20%	+21.11% TTM	-2.51% TTM	+22.32%
Dr. Reddy's Laboratories Ltd.	1,14,513	1,372.00	41.50	13.90%	-3.53% TTM	-51.90% TTM	+14.26%
Cipla Ltd.	1,13,110	1,400.10	39.63	14.90%	-0.74% TTM	-47.48% TTM	-6.88%
Mankind Pharma Limited	1,04,631	2,533.15	46.22	13.70%	+13.27% TTM	+27.60% TTM	+6.91%
Aurobindo Pharma Ltd.	97,878	1,701.10	26.38	13.60%	+9.09% TTM	+9.48% TTM	+47.79%
Lupin Ltd	92,145	2,015.00	17.65	28.40%	+24.22% TTM	+20.10% TTM	+0.84%
Glenmark Pharmaceuticals ltd	70,608	2,501.85	39.27	16.20%	+32.94% TTM	+138.48% TTM	+35.48%
Alkem Laboratories Limited	62,054	5,190.00	28.15	18.80%	+13.36% TTM	-5.52% TTM	-8.38%
Abbott India Ltd. S	57,685	27,146.85	35.73	41.90%	+6.29% TTM	+11.18% TTM	-7.56%
Biocon Ltd.	56,061	344.00	134.63	2.90%	+5.70% TTM	-55.37% TTM	-9.53%
Gland Pharma Limited	52,105	3,157.70	46.16	13.70%	+17.57% TTM	+46.55% TTM	+65.09%
Ipca Laboratories Ltd.	50,051	1,973.15	36.40	16.40%	+10.59% TTM	+67.91% TTM	+52.33%
GlaxoSmithkline Pharmaceuticals Ltd.	42,904	2,532.60	37.42	55.40%	+12.12% TTM	+20.03% TTM	-4.84%
Ajanta Pharma Ltd.	41,406	3,313.55	32.79	29.40%	+25.01% TTM	+29.70% TTM	+26.89%
Emcure Pharmaceuticals Limited	41,254	2,174.55	37.75	25.10%	+21.12% TTM	+33.34% TTM	+64.07%
J.B. Chemicals & Pharmaceuticals Lt	38,731	2,412.25	47.77	21.90%	+5.87% TTM	+7.56% TTM	+45.79%
Sai Life Sciences Limited	32,855	1,546.30	90.80	18.10%	—	—	+67.49%
PIRAMAL PHARMA LIMITED	31,659	237.80	-151.21	0.80%	+9.43% TTM	-781.93% TTM	+18.60%
ACUTAAS CHEMICALS LIMITED	30,928	3,777.65	70.51	27.70%	+45.18% TTM	+95.78% TTM	+106.30%
Wockhardt Ltd	30,869	1,899.80	76.22	6.40%	+25.70% TTM	+894.12% TTM	+39.18%
RUBICON RESEARCH LIMITED	28,416	1,716.55	98.59	24.30%	—	—	+164.06%
Venus Remedies Ltd.	1,851	1,384.95	15.21	19.40%	+20.22% TTM	+73.03% TTM	+212.42%

Filings & corporate actions

Recent announcements

As per the file enclosed.4 Nov 2026 · Company Update / Newspaper Publication
As per the file enclosed.28 Oct 2026 · Company Update / Newspaper Publication
As per the file enclosed.26 Oct 2026 · Result / Financial Results
Outcome of Board Meeting date 26th October 2026 and Unaudited Financial Results for the period ended on 30th September 2026.26 Oct 2026 · Board Meeting / Outcome of Board Meeting
As per the file enclosed.16 Oct 2026 · Company Update / General
As per the pdf enclosed.14 Oct 2026 · Company Update / General
Venus Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/10/2026 ,inter alia, to consider and approve As per the pdf enclosed.14 Oct 2026 · Board Meeting / Board Meeting
Compliance under Reg 74(5) of SEBI (DP) regulations.9 Oct 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
As per file enclosed.30 Sep 2026 · Company Update / General
Closure of trading window.25 Sep 2026 · Insider Trading / SAST / Closure of Trading Window
Newspaper publication of shareholder notice on Transfer of physical shares.10 Sep 2026 · Company Update / Newspaper Publication
Newspaper publication for shareholders awareness on transfer of physical shares.9 Sep 2026 · Company Update / Newspaper Publication
As per the pdf enclosed.8 Sep 2026 · Company Update / General
As per file enclosed.21 Aug 2026 · AGM/EGM / AGM
As per the file enclosed.21 Aug 2026 · Company Update / Amendments to Memorandum & Articles of Association
As per enclosed file.21 Aug 2026 · AGM/EGM / AGM
As per the file enclosed.20 Aug 2026 · Company Update / Change in Management
As per file enclosed.20 Aug 2026 · AGM/EGM / AGM
As per enclosed file.4 Aug 2026 · Company Update / Newspaper Publication
Newspaper publication of 37th AGM Notice.27 Jul 2026 · Company Update / Newspaper Publication
Annual report for FY 2025-26.24 Jul 2026 · Others / Reg. 34 (1) Annual Report
Annual report for the FY 2025-26.24 Jul 2026 · Others / Reg. 34 (1) Annual Report
As per the pdf enclosed.24 Jul 2026 · AGM/EGM / AGM
As per the pdf enclosed.22 Jul 2026 · Company Update / Newspaper Publication
As per the pdf enclosed.20 Jul 2026 · Company Update / Amendments to Memorandum & Articles of Association
As per pdf enclosed.20 Jul 2026 · Result / Financial Results
As per the pdf enclosed.20 Jul 2026 · Board Meeting / Outcome of Board Meeting
As per pdf enclosed.18 Jul 2026 · Company Update / General
As per the file enclosed.10 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Venus Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/07/2026 ,inter alia, to consider and approve This is to inform you that the ....9 Jul 2026 · Board Meeting / Board Meeting
As per the pdf enclosed.7 Jul 2026 · Company Update / General
Copy of newspaper publication for AGM prior Notice.3 Jul 2026 · Company Update / Newspaper Publication
Closure of Trading window25 Jun 2026 · Insider Trading / SAST / Closure of Trading Window
As per file enclosed.16 Jun 2026 · Company Update / General
As per the PDF enclosed.4 Jun 2026 · Company Update / General
As per enclosed file.28 May 2026 · Company Update / Newspaper Publication
As per the file enclosed26 May 2026 · Corp. Action / Dividend
AS per file enclosed.26 May 2026 · Company Update / General
Appointments & reappointments of directors.26 May 2026 · Company Update / Change in Management
As per file attached.26 May 2026 · Corp Action / Dividend Updates

Corporate actions

Purpose	Ex date	Record date	Payment date
Final Dividend - Rs. - 10.0000	7 Aug 2026	7 Aug 2026	—

Board meetings

26 Oct 2026 Board Meeting - Financial Results
20 Jul 2026 Board Meeting - Financial Results